Cited by 357Regulation of Appetite and ObesityAdipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and Metabolism

Asprosin is a centrally acting orexigenic hormone

Open access
Duerrschmid, Clemens, He, Yanlin, Wang, Chunmei, Li, Chia, Bournat, Juan C, Romere, Chase, Saha, Pradip K, Lee, Mark E +13 more·2017·Nature Medicine

Abstract

Asprosin is a recently discovered fasting-induced hormone that promotes hepatic glucose production. Here we demonstrate that asprosin in the circulation crosses the blood-brain barrier and directly activates orexigenic AgRP+ neurons via a cAMP-dependent pathway. This signaling results in inhibition of downstream anorexigenic proopiomelanocortin (POMC)-positive neurons in a GABA-dependent manner, which then leads to appetite stimulation and a drive to accumulate adiposity and body weight. In humans, a genetic deficiency in asprosin causes a syndrome characterized by low appetite and extreme leanness; this is phenocopied by mice carrying similar mutations and can be fully rescued by asprosin. Furthermore, we found that obese humans and mice had pathologically elevated concentrations of circulating asprosin, and neutralization of asprosin in the blood with a monoclonal antibody reduced appetite and body weight in obese mice, in addition to improving their glycemic profile. Thus, in addition to performing a glucogenic function, asprosin is a centrally acting orexigenic hormone that is a potential therapeutic target in the treatment of both obesity and diabetes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nm.4432

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Asprosin can directly target the CNS to increase food intake.

    “Additionally, asprosin can directly target the central nervous system (CNS) to increase food intake 60.”
  • Circulating asprosin levels are higher in obese humans and mice.

    “Circulating asprosin levels are higher in obese humans and mice 60.”
  • High asprosin could contribute to the difficulties to obtain a voluntary reduction in food intake in obese patients due to its orexigenic effects.

    “Due to the orexigenic effects of this hormone, this alteration could contribute to the difficulties to obtain a voluntary reduction in food intake in obese patients 60.”
  • Asprosin can be targeted to modulate food intake and lower glycemia in obese subjects.

    “More recently, a neutralizing antibody against asprosin was used in obese mice to reduce appetite, body weight, and blood glucose, suggesting that this orexigenic hormone can be targeted to modulate food intake and lower glycemia in obese subjects 60.”
  • A neutralizing antibody against asprosin reduces appetite, body weight, and blood glucose in obese mice.

    “More recently, a neutralizing antibody against asprosin was used in obese mice to reduce appetite, body weight, and blood glucose, suggesting that this orexigenic hormone can be targeted to modulate food intake and lower glycemia in obese subjects 60.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Duerrschmid, C., He, Y., Wang, C., Li, C., Bournat, J. C., Romere, C., Saha, P. K., Lee, M. E., Phillips, K. J., Jain, M., Jia, P., Zhao, Z., Farias, M., Wu, Q., Milewicz, D. M., Sutton, V. R., Moore, D. D., Butte, N. F., Krashes, M. J., Xu, Y., & Chopra, A. R.
Affiliations
  • Baylor College of Medicine (US)
  • National Institutes of Health (US)
  • Kennedy Krieger Institute (US)
  • The University of Texas Health Science Center at Houston (US)
Corresponding author
  • Xu, Yong
  • Chopra, Atul R
Venue
Nature Medicine
Published
2017-11-06
Volume
23
Issue
12
Pages
1444-1453
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W2767694961
Cited by
357
References
32
Citations by year
2026: 45 · 2025: 37 · 2024: 45 · 2023: 44 · 2022: 55 · 2021: 48 · 2020: 38 · 2019: 27 · 2018: 16 · 2012: 1
FWCI
13.58
Type
journal article
Language
en
Open access
Locations
  • Nature Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • American Diabetes Association (1-17-PDF-138, 16POST27260254)
  • American Heart Association (16POST29630010)
  • National Institutes of Health (5r01dk111631-04)
  • National Human Genome Research Institute (UM1HG006542, UM1HG006348)
  • National Cancer Institute (P30CA125123, P30CA016086)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK101379, K08DK102529, P30DK079638, R01 DK111631, R01DK093587, R56DK109194)
  • U.S. National Library of Medicine (R01LM012806)
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
Keywords
asprosin, orexigenic hormones, food intake regulation, AgRP neurons, POMC neurons, GABA signaling, cAMP signaling, blood-brain barrier, hepatic glucose production, appetite, obesity, diabetes mellitus, adipose tissue, monoclonal antibodies, body weight
MeSH terms
Fibrillin-1, Adolescent, Adult, Animals, Appetite Depressants, Appetite Regulation, Female, Humans, Hypothalamus, Male, Mice, Inbred C57BL, Mice, Transgenic, Microfilament Proteins, Neurons, Peptide Fragments, Signal Transduction, Peptide Hormones, Mice, Rats, Adipokines, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review